Catalyst Pharmaceuticals (CPRX) Free Cash Flow (2010 - 2026)
Catalyst Pharmaceuticals posted quarterly Free Cash Flow of $59.6 million for Q1 2026, down 0.8% year-on-year from $60.0 million in Q1 2025, and up 32.77% on a QoQ basis from $44.9 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) has 17 years of Free Cash Flow data on file, last reported at $59.6 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 0.8% year-over-year to $59.6 million; the trailing twelve-month figure through Mar 2026 stood at $208.1 million (down 22.21% YoY), and the FY2025 full-year result was $208.6 million, down 12.81% from the prior year.
- Free Cash Flow for Q1 2026 stood at $59.6 million, up from $44.9 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $72.6 million in Q3 2024 and bottomed at $8.5 million in Q1 2022.
- The 5-year median for Free Cash Flow is $44.9 million (2025), against an average of $45.1 million.
- The widest annual swing landed in 2022, when Free Cash Flow jumped 192.04%; it then plunged 55.33% in 2025.
- A 5-year view of Free Cash Flow shows it stood at $40.1 million in 2022, then surged by 38.62% to $55.6 million in 2023, then advanced by 27.42% to $70.8 million in 2024, then plunged by 36.63% to $44.9 million in 2025, then soared by 32.77% to $59.6 million in 2026.
- The last three Free Cash Flow figures came in at $59.6 million (Q1 2026), $44.9 million (Q4 2025), and $32.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 59.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.56 Mn |
| Mar 31, 2026 | 59.56 Mn |
| Dec 31, 2025 | 44.86 Mn |
| Dec 31, 2025 | 44.86 Mn |
| Sep 30, 2025 | 32.44 Mn |
| Sep 30, 2025 | 32.44 Mn |
| Jun 30, 2025 | 71.27 Mn |
| Jun 30, 2025 | 71.27 Mn |
| Mar 31, 2025 | 60.04 Mn |
| Mar 31, 2025 | 60.04 Mn |
| Dec 31, 2024 | 70.79 Mn |
| Dec 31, 2024 | 70.79 Mn |
| Sep 30, 2024 | 72.61 Mn |
| Sep 30, 2024 | 72.61 Mn |
| Jun 30, 2024 | 64.13 Mn |
| Jun 30, 2024 | 64.13 Mn |
| Mar 31, 2024 | 31.73 Mn |
| Mar 31, 2024 | 31.73 Mn |
| Dec 31, 2023 | 55.56 Mn |
| Dec 31, 2023 | 55.56 Mn |
| Sep 30, 2023 | 45.06 Mn |
| Sep 30, 2023 | 45.06 Mn |
| Jun 30, 2023 | 30.75 Mn |
| Jun 30, 2023 | 30.75 Mn |
| Mar 31, 2023 | 12.00 Mn |
| Mar 31, 2023 | 12.00 Mn |
| Dec 31, 2022 | 40.08 Mn |
| Dec 31, 2022 | 40.08 Mn |
| Sep 30, 2022 | 41.30 Mn |
| Sep 30, 2022 | 41.30 Mn |
| Jun 30, 2022 | 26.19 Mn |
| Jun 30, 2022 | 26.19 Mn |
| Mar 31, 2022 | 8.48 Mn |
| Mar 31, 2022 | 8.48 Mn |
| Dec 31, 2021 | 19.14 Mn |
| Dec 31, 2021 | 19.14 Mn |
| Sep 30, 2021 | 21.64 Mn |
| Sep 30, 2021 | 21.64 Mn |
| Jun 30, 2021 | 15.67 Mn |
| Jun 30, 2021 | 15.67 Mn |
| Mar 31, 2021 | 2.90 Mn |
| Mar 31, 2021 | 2.90 Mn |
| Dec 31, 2020 | 13.11 Mn |
| Dec 31, 2020 | 13.11 Mn |
| Sep 30, 2020 | 11.45 Mn |
| Sep 30, 2020 | 11.45 Mn |
| Jun 30, 2020 | 13.27 Mn |
| Jun 30, 2020 | 13.27 Mn |
| Mar 31, 2020 | 7.21 Mn |
| Mar 31, 2020 | 7.21 Mn |
| Dec 31, 2019 | 12.29 Mn |
| Dec 31, 2019 | 12.29 Mn |
| Sep 30, 2019 | 16.26 Mn |
| Sep 30, 2019 | 16.26 Mn |
| Jun 30, 2019 | 14.06 Mn |
| Jun 30, 2019 | 14.06 Mn |
| Mar 31, 2019 | -8.02 Mn |
| Mar 31, 2019 | -8.02 Mn |
| Dec 31, 2018 | -8.41 Mn |
| Dec 31, 2018 | -8.41 Mn |
| Sep 30, 2018 | -6.98 Mn |
| Sep 30, 2018 | -6.98 Mn |
| Jun 30, 2018 | -4.77 Mn |
| Jun 30, 2018 | -4.77 Mn |
| Mar 31, 2018 | -6.08 Mn |
| Mar 31, 2018 | -6.08 Mn |
| Dec 31, 2017 | -4.03 Mn |
| Dec 31, 2017 | -4.03 Mn |
| Sep 30, 2017 | -2.63 Mn |
| Sep 30, 2017 | -2.63 Mn |
| Jun 30, 2017 | -3.20 Mn |
| Jun 30, 2017 | -3.20 Mn |
| Mar 31, 2017 | -3.88 Mn |
| Mar 31, 2017 | -3.88 Mn |
| Dec 31, 2016 | -4.42 Mn |
| Dec 31, 2016 | -4.42 Mn |
| Sep 30, 2016 | -3.28 Mn |
| Sep 30, 2016 | -3.28 Mn |
| Jun 30, 2016 | -4.34 Mn |
| Jun 30, 2016 | -4.34 Mn |
| Mar 31, 2016 | -5.93 Mn |
| Mar 31, 2016 | -5.93 Mn |
| Dec 31, 2015 | -4.63 Mn |
| Dec 31, 2015 | -4.63 Mn |
| Sep 30, 2015 | -5.36 Mn |
| Sep 30, 2015 | -5.36 Mn |
| Jun 30, 2015 | -4.25 Mn |
| Jun 30, 2015 | -4.25 Mn |
| Mar 31, 2015 | -3.80 Mn |
| Mar 31, 2015 | -3.80 Mn |
| Dec 31, 2014 | -3.99 Mn |
| Dec 31, 2014 | -3.99 Mn |
| Sep 30, 2014 | -3.57 Mn |
| Sep 30, 2014 | -3.57 Mn |
| Jun 30, 2014 | -3.00 Mn |
| Jun 30, 2014 | -3.00 Mn |
| Mar 31, 2014 | -2.44 Mn |
| Mar 31, 2014 | -2.44 Mn |
| Dec 31, 2013 | -4.13 Mn |
| Dec 31, 2013 | -4.13 Mn |
| Sep 30, 2013 | -1.68 Mn |
| Sep 30, 2013 | -1.68 Mn |
| Jun 30, 2013 | -1.81 Mn |
| Jun 30, 2013 | -1.81 Mn |
| Mar 31, 2013 | -2.26 Mn |
| Mar 31, 2013 | -2.26 Mn |
| Dec 31, 2012 | -1.64 Mn |
| Dec 31, 2012 | -1.64 Mn |
| Sep 30, 2012 | -1.10 Mn |
| Sep 30, 2012 | -1.10 Mn |
| Jun 30, 2012 | -1.15 Mn |
| Jun 30, 2012 | -1.15 Mn |
| Mar 31, 2012 | -1.31 Mn |
| Mar 31, 2012 | -1.31 Mn |
| Dec 31, 2011 | -1.44 Mn |
| Dec 31, 2011 | -1.44 Mn |
| Sep 30, 2011 | -1.25 Mn |
| Sep 30, 2011 | -1.25 Mn |
| Jun 30, 2011 | -1.46 Mn |
| Jun 30, 2011 | -1.46 Mn |
| Mar 31, 2011 | -831,119.00 |
| Mar 31, 2011 | -831,119.00 |
| Dec 31, 2010 | -769,152.00 |
| Dec 31, 2010 | -769,152.00 |
| Sep 30, 2010 | -817,344.00 |
| Sep 30, 2010 | -817,344.00 |